Kevin C. Tang

Companies

• Aurinia Pharmaceuticals Inc.Chief executive officer Jun 2, 2026 to now¹
• Aurinia Pharmaceuticals Inc.Board member Sep 23, 2024 to now²
• Jounce TherapeuticsBoard member May 5, 2023 to May 5, 2023³
• La Jolla Pharmaceutical CompanyChief financial officer Jun 4, 2020 to Aug 24, 2022⁴
• La Jolla Pharmaceutical CompanyBoard member Sep 26, 2014 to Aug 24, 2022⁵
• Odonate Therapeutics, Inc.Board member Dec 6, 2017 to Nov 19, 2021⁶
• Odonate Therapeutics, Inc.Chief executive officer Dec 6, 2017 to Nov 19, 2021⁶
• HERON THERAPEUTICS, INC. /DE/Board member Oct 21, 2009 to Feb 14, 2020⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APAurinia Pharmaceuticals Inc. AUPH13,044,106 shares⁸$215.4M at $16.51Jun 2, 2026
• JPLa Jolla Pharmaceutical Company0 shares⁹Aug 22, 2022
• JTJounce Therapeutics JNCE10,000 shares¹⁰May 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 21, 2026Bought 2,975 shares at $2.44 of Boundless Bio (United States)¹¹
• Jul 20, 2026Bought 1,623 shares at $2.44 of Boundless Bio (United States)¹¹
• Jul 17, 2026Bought 50,945 shares at $3.52 of Fulcrum Therapeutics (United States)¹²
• Jul 17, 2026Bought 265 shares at $2.44 of Boundless Bio (United States)¹¹
• Jul 16, 2026Bought 18,491 shares at $2.44 of Boundless Bio (United States)¹³
• Jul 16, 2026Bought 116,671 shares at $3.56 of Fulcrum Therapeutics (United States)¹²
• Jul 15, 2026Bought 1,600 shares at $2.44 of Boundless Bio (United States)¹³
• Jul 14, 2026Bought 43,878 shares at $2.43 of Boundless Bio (United States)¹³
• Jul 13, 2026Bought 48,211 shares at $2.42 of Boundless Bio (United States)¹⁴
• Jul 10, 2026Bought 43,367 shares at $2.43 of Boundless Bio (United States)¹⁴
• Jul 9, 2026Bought 7 shares at $2.48 of Boundless Bio (United States)¹⁴
• Jul 8, 2026Bought 14,338 shares at $2.46 of Boundless Bio (United States)¹⁵
• Jul 7, 2026Bought 15,810 shares at $2.48 of Boundless Bio (United States)¹⁵
• Jul 6, 2026Bought 27,062 shares at $2.49 of Boundless Bio (United States)¹⁵
• Jul 2, 2026Bought 9,821 shares at $2.49 of Boundless Bio (United States)¹⁶
• Jul 1, 2026Bought 71,612 shares at $2.49 of Boundless Bio (United States)¹⁶
• Jun 30, 2026Bought 100 shares at $2.50 of Boundless Bio (United States)¹⁶
• Jun 30, 2026Bought 25,930 shares at $2.54 of Boundless Bio (United States)¹⁶
• Jun 29, 2026Bought 777 shares at $2.48 of Boundless Bio (United States)¹⁷
• Jun 29, 2026Bought 63,985 shares at $2.47 of Boundless Bio (United States)¹⁷
• Jun 26, 2026Bought 134 shares at $2.54 of Boundless Bio (United States)¹⁷
• Jun 26, 2026Bought 75,047 shares at $2.55 of Boundless Bio (United States)¹⁷
• Jun 25, 2026Bought 510 shares at $2.56 of Boundless Bio (United States)¹⁷
• Jun 25, 2026Bought 145,880 shares at $2.48 of Boundless Bio (United States)¹⁷
• Jun 2, 2026Bought 206,005 shares at $15.28 of Aurinia Pharmaceuticals Inc.⁸